xamoterol has been researched along with diflunisal in 2 studies
Studies (xamoterol) | Trials (xamoterol) | Recent Studies (post-2010) (xamoterol) | Studies (diflunisal) | Trials (diflunisal) | Recent Studies (post-2010) (diflunisal) |
---|---|---|---|---|---|
269 | 80 | 17 | 605 | 129 | 145 |
Protein | Taxonomy | xamoterol (IC50) | diflunisal (IC50) |
---|---|---|---|
Carbonic anhydrase 1 | Homo sapiens (human) | 3.38 | |
Carbonic anhydrase 2 | Homo sapiens (human) | 2.7 | |
Transthyretin | Homo sapiens (human) | 5.4667 | |
Solute carrier family 22 member 6 | Homo sapiens (human) | 0.85 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
2 other study(ies) available for xamoterol and diflunisal
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |